4//SEC Filing
Bodenstedt Matthias 4
Accession 0001213900-25-097594
CIK 0001821586other
Filed
Oct 8, 8:00 PM ET
Accepted
Oct 9, 9:01 AM ET
Size
5.1 KB
Accession
0001213900-25-097594
Insider Transaction Report
Form 4
Bodenstedt Matthias
Chief Financial Officer
Transactions
- Purchase
Class A ordinary shares, par value $0.0001 per share
2025-10-08$9.09/sh+10,870$98,808→ 627,536 total
Footnotes (1)
- [F1]The price reported represents the weighted average purchase price per share. The shares were purchased in multiple transactions at prices ranging from $9.085 to $9.091244. Upon request by the staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares purchased at each separate price.
Documents
Issuer
MoonLake Immunotherapeutics
CIK 0001821586
Entity typeother
Related Parties
1- filerCIK 0001920545
Filing Metadata
- Form type
- 4
- Filed
- Oct 8, 8:00 PM ET
- Accepted
- Oct 9, 9:01 AM ET
- Size
- 5.1 KB